Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics
- PMID:24928218
- PMCID: PMC4084498
- DOI: 10.1186/1940-0640-9-9
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics
Abstract
Background: Tobacco cessation medication adherence is one of the few factors shown to improve smoking cessation rates among methadone-maintained smokers, but interventions to improve adherence to smoking cessation medications have not yet been tested among methadone treatment patients. Methadone clinic-based, directly observed therapy (DOT) programs for HIV and tuberculosis improve adherence and clinical outcomes, but have not been evaluated for smoking cessation. We describe a randomized controlled trial to evaluate whether a methadone clinic-based, directly observed varenicline therapy program increases adherence and tobacco abstinence among opioid-dependent drug users receiving methadone treatment.
Methods/design: We plan to enroll 100 methadone-maintained smokers and randomize them to directly observed varenicline dispensed with daily methadone doses or treatment as usual (self-administered varenicline) for 12 weeks. Our outcome measures are: 1) pill count adherence and 2) carbon monoxide-verified tobacco abstinence. We will assess differences in adherence and abstinence between the two treatment arms using repeated measures models.
Discussion: This trial will allow for rigorous evaluation of the efficacy of methadone clinic-based, directly observed varenicline for improving adherence and smoking cessation outcomes. This detailed description of trial methodology can serve as a template for the development of future DOT programs and can guide protocols for studies among opioid-dependent smokers receiving methadone treatment.
Trial registration: clinicaltrials.govNCT01378858.
Figures
Similar articles
- Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial.Nahvi S, Adams TR, Ning Y, Zhang C, Arnsten JH.Nahvi S, et al.Addiction. 2021 Apr;116(4):902-913. doi: 10.1111/add.15240. Epub 2020 Oct 13.Addiction. 2021.PMID:32857445Free PMC article.Clinical Trial.
- Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.Stein MD, Caviness CM, Kurth ME, Audet D, Olson J, Anderson BJ.Stein MD, et al.Drug Alcohol Depend. 2013 Dec 1;133(2):486-93. doi: 10.1016/j.drugalcdep.2013.07.005. Epub 2013 Aug 14.Drug Alcohol Depend. 2013.PMID:23953658Free PMC article.Clinical Trial.
- Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.Nahvi S, Ning Y, Segal KS, Richter KP, Arnsten JH.Nahvi S, et al.Addiction. 2014 Sep;109(9):1554-63. doi: 10.1111/add.12631. Epub 2014 Jun 27.Addiction. 2014.PMID:24862167Free PMC article.Clinical Trial.
- Nicotine receptor partial agonists for smoking cessation.Cahill K, Stead LF, Lancaster T.Cahill K, et al.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.Cochrane Database Syst Rev. 2012.Update in:Cochrane Database Syst Rev. 2016 May 09;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.PMID:22513936Updated.Review.
- Nicotine receptor partial agonists for smoking cessation.Cahill K, Stead LF, Lancaster T.Cahill K, et al.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.Cochrane Database Syst Rev. 2011.Update in:Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.PMID:21328282Updated.Review.
Cited by
- Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial.Nahvi S, Adams TR, Ning Y, Zhang C, Arnsten JH.Nahvi S, et al.Addiction. 2021 Apr;116(4):902-913. doi: 10.1111/add.15240. Epub 2020 Oct 13.Addiction. 2021.PMID:32857445Free PMC article.Clinical Trial.
- Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.Miller ME, Sigmon SC.Miller ME, et al.Nicotine Tob Res. 2015 Aug;17(8):955-9. doi: 10.1093/ntr/ntv030.Nicotine Tob Res. 2015.PMID:26180219Free PMC article.Review.
- Achieving Smoking Cessation Among Persons with Opioid Use Disorder.Vlad C, Arnsten JH, Nahvi S.Vlad C, et al.CNS Drugs. 2020 Apr;34(4):367-387. doi: 10.1007/s40263-020-00701-z.CNS Drugs. 2020.PMID:32107731Free PMC article.Review.
- Nicotine receptor partial agonists for smoking cessation.Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N.Livingstone-Banks J, et al.Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.Cochrane Database Syst Rev. 2023.PMID:37142273Free PMC article.Review.
- Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders.Nahvi S, Arnsten JH.Nahvi S, et al.Drug Alcohol Depend. 2018 Apr;185:245-247. doi: 10.1016/j.drugalcdep.2018.02.001. Epub 2018 Feb 22.Drug Alcohol Depend. 2018.PMID:30369710Free PMC article.No abstract available.
References
- Centers for Disease Control and Prevention. State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18–35 years—United States, 2006. MMWR. 2007;56:993–996. - PubMed
- Nahvi S, Richter K, Li X, Modali L, Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav. 2006;31:2127–2134. - PubMed
- Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton LJ 3rd. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275:1097–1103. - PubMed
- Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. 1994;23:61–69. - PubMed
Publication types
MeSH terms
Substances
Associated data
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical